Prevalence of Oral Mucosal Alterations In a Sample of Egyptian Patients With Cardiovascular Diseases: A Hospital- Based Cross-Sectional Study
NCT04511403 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 338
Last updated 2020-08-13
Summary
to assess the oral mucosal alterations and their prevalence secondary to use cardiovascular drugs in a sample of Egyptian population with cardiovascular diseases .
Conditions
- Cardiac Disease
Sponsors & Collaborators
-
Cairo University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-09-30
- Primary Completion
- 2022-09-30
- Completion
- 2022-10-31
More Related Trials
-
Exploratory Study in the Relief of Drug-induced Xerostomia Associated With Hyposialia
NCT02005328 ·Status: COMPLETED ·Phase: NA
-
Effect of Natural Antibacterial Mouthwash on Taste, Salivary pH and Bacteria in High Caries Risk pt
NCT03623048 ·Status: UNKNOWN ·Phase: NA
-
Oral Ulcer Prevalence: Hospital-based Cross-sectional Study
NCT03167632 ·Status: COMPLETED
-
Oral Symptoms of COVID-19 Among Infected Medical Doctors
NCT05697081 ·Status: COMPLETED
-
Proper Nutrition And Its Relation To Oral Diseases In Covid -19 Era
NCT04434014 ·Status: UNKNOWN
-
Salivary Proteins in Disease and Health
NCT00100204 ·Status: COMPLETED
-
Oral Manifestations of Coronavirus Disease 2019(COVID-19) :a Multicentre Study
NCT04487665 ·Status: UNKNOWN
-
Oral Manifestation in Patients With SARS-CoV2 Infection.
NCT04821986 ·Status: COMPLETED
-
Artificial Intelligence Based Program to Classify Oral Cavity Findings Based on Clinical Image Analysis
NCT06325514 ·Status: COMPLETED
-
Recurrent Salivary Gland Infections in Covid-19
NCT05890547 ·Status: UNKNOWN
-
Salivary Markers in Patients With Xerostomia
NCT03156569 ·Status: COMPLETED
-
Effect of Oral Water in Healthy Volunteers on Cardiac Output, Regional Flow and Microcirculation in Healthy Volunteers
NCT05153837 ·Status: COMPLETED ·Phase: NA
-
the Prevalence of Oral Manifestation in Patients With SARS-CoV2 Infection
NCT04893694 ·Status: COMPLETED
-
the Effect of Mixture of Natural Products As Salivary Substitutes in Treatment Of Xerostomia
NCT04252209 ·Status: COMPLETED ·Phase: PHASE3
-
Consumer Perception of an Experimental Mouthwash After a Single Use in Dry Mouth Subjects
NCT03005041 ·Status: COMPLETED ·Phase: NA
-
Interest of Auriculotherapy in the Treatment of Xerostomia
NCT04222478 ·Status: RECRUITING ·Phase: NA
-
A New Oral salIvary equivAlent Compared to Two moisturizinG Mouth sprAys in Patients With xeRostomiA: NIAGARA Study
NCT02049112 ·Status: COMPLETED ·Phase: PHASE4
-
COVID-19 Vaccine Hesitancy and Dental Faculty Staff Members in Egypt
NCT05009043 ·Status: UNKNOWN
-
Diagnostic Accuracy of Salivary DNA Integrity Index in Oral Malignant and Premalignant Lesions
NCT03682562 ·Status: COMPLETED
-
Evaluation and Treatment of Oral Soft Tissue Diseases
NCT00001601 ·Status: COMPLETED ·Phase: NA
-
Beneficial Effects of Natural Products on Management of Xerostomia
NCT06217614 ·Status: COMPLETED ·Phase: NA
-
Effects of Hydroxychloroquine on Oral Complaints of Sjögren Patients
NCT00873496 ·Status: COMPLETED
-
Gingival Wetness and Gingival Crevicular Fluid Volume in Patients With Dry Mouth
NCT00750828 ·Status: COMPLETED
-
Hormonal Status and Quality of Life in Female Postmenopausal Patients With Burning Mouth Syndrome
NCT04535973 ·Status: COMPLETED
-
Evaluation of the Salivary-free Amino Acids Levels (Glycine , Proline , Lysine , and Alanine ) With Caries Activity
NCT06953557 ·Status: NOT_YET_RECRUITING